Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether subcutaneous immunoglobulin given in small
doses, is effective in maintaining the force, in patients with chronic inflammatory
demyelinating polyradiculoneuropathy compared with placebo (saline infusions), and
intravenous immunoglobulin.
Phase:
Phase 2
Details
Lead Sponsor:
University of Aarhus
Collaborators:
Baxter Healthcare Corporation GCP-unit at Aarhus University Hospital, Aarhus, Denmark